{
  "url": "https://openlegislation.uk/eu-regulation-2009-983/annex-I",
  "json_url": "https://openlegislation.uk/eu-regulation-2009-983/annex-I.json",
  "legislation": "eur/2009/983",
  "legislation_title": "Commission Regulation (EC) No 983/2009 of 21 October 2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2009-983",
  "path": "annex/I",
  "kind": "annex",
  "number": "I",
  "heading": null,
  "text": "PERMITTED HEALTH CLAIMS\nApplication – Relevant provisions of Regulation (EC) No 1924/2006\nApplicant – Address\nNutrient, substance, food or food category\nClaim\nConditions of use of the claim\nConditions and/or restrictions of use of the food and/or additional statement or warning\nEFSA opinion reference\nArticle 14(1)(a) health claim referring to reduction of disease risk\nUnilever PLC; Port Sunlight, Wirral, Merseyside, CH62 4ZD, UK and Unilever NV, Weena 455, Rotterdam, 3013 AL, Nederland\nPlant sterols: Sterols extracted from plants, free or esterified with food grade fatty acids\nPlant sterols have been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease\nInformation to the consumer that the beneficial effect is obtained with a daily intake of 1,5-3 g plant sterols. Reference to the magnitude of the effect may only be made for foods within the following categories: yellow fat spreads, dairy products, mayonnaise and salad dressings. When referring to the magnitude of the effect, the range ‘7 % to 10 %’ for foods that provide a daily intake of 1,5-2,4 g plant sterols or the range ‘10 % to 12,5 %’ for foods that provide a daily intake of 2,5-3 g plant sterols and the duration to obtain the effect ‘in 2 to 3 weeks’ must be communicated to the consumer.\nQ-2008-085\nQ-2009-00530 and Q-2009-00718\nQ-2011-01241\nArticle 14(1)(a) health claim referring to reduction of disease risk\nMcNeil Nutritionals, 1 Landis und Gyr Strasse, 6300 Zug; Switzerland\nPlant stanol esters\nPlant stanol esters have been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease\nInformation to the consumer that the beneficial effect is obtained with a daily intake of 1,5-3 g plant sterols/stanols. Reference to the magnitude of the effect may only be made for foods within the following categories: yellow fat spreads, dairy products, mayonnaise and salad dressings. When referring to the magnitude of the effect, the range ‘7 % to 10 %’ for foods that provide a daily intake of 1,5-2,4 g plant sterols/stanols or the range ‘10 % to 12,5 %’ for foods that provide a daily intake of 2,5-3 g plant sterols/stanols and the duration to obtain the effect ‘in 2 to 3 weeks’ must be communicated to the consumer.\nQ-2008-118\nQ-2009-00530 and Q-2009-00718\nQ-2011-00851\nQ-2011-01241\nArticle 14(1)(b) health claim referring to children’s development and health\nUnilever PLC; Port Sunlight, Wirral, Merseyside, CH62 4ZD, UK and Unilever NV, Weena 455, Rotterdam, 3013 AL, Nederland\nα-linolenic acid & linoleic acid\nEssential fatty acids are needed for normal growth and development of children\nInformation to the consumer that the beneficial effect is obtained with a daily intake of 2 g of α-linolenic acid (ALA) and a daily intake of 10 g of linoleic acid (LA)\nQ-2008-079\nArticle 14(1)(b) health claim referring to children’s development and health\nAssociation de la Transformation Laitière Française (ATLA), 42, rue du Châteaudun, 75314 Paris Cedex 09, FRANCE\nCalcium\nCalcium is needed for normal growth and development of bone in children\nThe claim can be used only for food which is at least a source of calcium as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006\nQ-2008-322\nArticle 14(1)(b) health claim referring to children’s development and health\nAssociation de la Transformation Laitière Française (ATLA), 42, rue du Châteaudun, 75314 Paris Cedex 09, FRANCE\nProtein\nProtein is needed for normal growth and development of bone in children\nThe claim can be used only for food which is at least a source of protein as referred to in the claim SOURCE OF PROTEIN as listed in the Annex to Regulation (EC) No 1924/2006\nQ-2008-326\nArticle 14(1)(b) health claim referring to children’s development and health\nYoplait Dairy Crest Ltd, Claygate House, Claygate, Surrey, KT10 9PN, UK\nCalcium and vitamin D\nCalcium and vitamin D are needed for normal growth and development of bone in children\nThe claim can be used only for food which is at least a source of calcium and vitamin D as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006\nQ-2008-116\nArticle 14(1)(b) health claim referring to children’s development and health\nAssociation de la Transformation Laitière Française (ATLA), 42, rue du Châteaudun, 75314 Paris Cedex 09, FRANCE\nVitamin D\nVitamin D is needed for normal growth and development of bone in children\nThe claim can be used only for food which is at least a source of Vitamin D as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006\nQ-2008-323",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Substituted by Commission Regulation (EU) No 686/2014 of 20 June 2014 amending Regulations (EC) No 983/2009 and (EU) No 384/2010 as regards the conditions of use of certain health claims related to the lowering effect of plant sterols and plant stanols on blood LDL-cholesterol (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Substituted by Commission Regulation (EU) No 376/2010 of 3 May 2010 amending Regulation (EC) No 983/2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2009/983/annex/I",
    "retrieved_at": "2026-11-01T14:51:11.796519+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}